Historical Valuation
HeartSciences Inc (HSCS) is now in the Fair zone, suggesting that its current forward PS ratio of 33.27 is considered Fairly compared with the five-year average of -1.19. The fair price of HeartSciences Inc (HSCS) is between 0.43 to 4.07 according to relative valuation methord.
Relative Value
Fair Zone
0.43-4.07
Current Price：3.35
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
HeartSciences Inc (HSCS) has a current Price-to-Book (P/B) ratio of 2.31. Compared to its 3-year average P/B ratio of -0.01 , the current P/B ratio is approximately -26146.70% higher. Relative to its 5-year average P/B ratio of 0.91, the current P/B ratio is about 152.88% higher. HeartSciences Inc (HSCS) has a Forward Free Cash Flow (FCF) yield of approximately -75.27%. Compared to its 3-year average FCF yield of -131.11%, the current FCF yield is approximately -42.59% lower. Relative to its 5-year average FCF yield of -116.18% , the current FCF yield is about -35.22% lower.
P/B
Median3y
-0.01
Median5y
0.91
FCF Yield
Median3y
-131.11
Median5y
-116.18
Competitors Valuation Multiple
AI Analysis for HSCS
The average P/S ratio for HSCS competitors is 11.23, providing a benchmark for relative valuation. HeartSciences Inc Corp (HSCS.O) exhibits a P/S ratio of 33.27, which is 196.27% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
AI Analysis for HSCS
1Y
3Y
5Y
Market capitalization of HSCS increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of HSCS in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is HSCS currently overvalued or undervalued?
HeartSciences Inc (HSCS) is now in the Fair zone, suggesting that its current forward PS ratio of 33.27 is considered Fairly compared with the five-year average of -1.19. The fair price of HeartSciences Inc (HSCS) is between 0.43 to 4.07 according to relative valuation methord.
What is HeartSciences Inc (HSCS) fair value?
HSCS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of HeartSciences Inc (HSCS) is between 0.43 to 4.07 according to relative valuation methord.
How does HSCS's valuation metrics compare to the industry average?
The average P/S ratio for HSCS's competitors is 11.23, providing a benchmark for relative valuation. HeartSciences Inc Corp (HSCS) exhibits a P/S ratio of 33.27, which is 196.27% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for HeartSciences Inc (HSCS) as of Jan 09 2026?
As of Jan 09 2026, HeartSciences Inc (HSCS) has a P/B ratio of 2.31. This indicates that the market values HSCS at 2.31 times its book value.
What is the current FCF Yield for HeartSciences Inc (HSCS) as of Jan 09 2026?
As of Jan 09 2026, HeartSciences Inc (HSCS) has a FCF Yield of -75.27%. This means that for every dollar of HeartSciences Inc’s market capitalization, the company generates -75.27 cents in free cash flow.
What is the current Forward P/E ratio for HeartSciences Inc (HSCS) as of Jan 09 2026?
As of Jan 09 2026, HeartSciences Inc (HSCS) has a Forward P/E ratio of -0.92. This means the market is willing to pay $-0.92 for every dollar of HeartSciences Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for HeartSciences Inc (HSCS) as of Jan 09 2026?
As of Jan 09 2026, HeartSciences Inc (HSCS) has a Forward P/S ratio of 33.27. This means the market is valuing HSCS at $33.27 for every dollar of expected revenue over the next 12 months.